California Controversy: Let's Not Expand the Market in Women's Eggs
By Marcy Darnovsky and Susan Berke Fogel,
Huffington Post
| 09. 03. 2013
Last month, California Governor Jerry Brown vetoed a bill that would have allowed researchers to pay women for having their eggs harvested and retrieved. His move was warmly welcomed by women's health and public interest groups including Our Bodies Ourselves, National Women's Health Network, Pro-Choice Alliance for Responsible Research, Alliance for Humane Biotechnology and Center for Genetics and Society. (Disclosure: see author affiliations.)
Echoing the longstanding concerns of many progressives about the serious risks of egg retrieval, Governor Brown's brief but eloquent veto message recognized that "in medical procedures of this kind, genuinely informed consent is difficult because the long term risks are not adequately known." He also acknowledged that low-income women would face disproportionate temptations to discount the risks. "Putting thousands of dollars on the table only compounds the problem," Brown wrote.
The vetoed bill, AB 926, was sponsored by the fertility industry's trade organization, the American Society for Reproductive Medicine. It was supported by several mainstream women's organizations, and breezed through the Democratic-dominated legislature. Ironically, as Governor Brown noted, the law that this bill would have overturned...
Related Articles
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
By Adam Zewe, MIT News | 02.07.2024
A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.
In cell therapy, clinicians...